Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$266.30
▲ $2.49 (+0.94%) today
Markets closed · 11:45pm ET

JNJ Coverage Page 49

11:40am ET
Health and Healthcare

Why Arrowhead Pharma’s New Agreement Is a Big Deal

Arrowhead Pharmaceuticals shares stumbled on Thursday after it announced a license and collaboration agreement with Janssen Pharmaceutica, a subsidiary of Johnson & Johnson.

JNJ
Chris Lange